Clarity AD

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Lecanemab IVOngoingActive not recruitingPhase 3Open NCT03887455 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…